No Data
Form 144 | Janux Therapeutics(JANX.US) 10% Stockholder Proposes to Sell 6.08 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Oct 18, $Janux Therapeutics(JANX.US)$ 10% Stockholder Avalon BioVentures SPV I, L.P. intends to sell 120.68K shares of its common stock on Oct 18, with a total market value
Form 144 | Janux Therapeutics(JANX.US) 10% Stockholder Proposes to Sell 4.57 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Oct 16, $Janux Therapeutics(JANX.US)$ 10% Stockholder Avalon BioVentures SPV I, L.P. intends to sell 91,539 shares of its common stock on Oct 16, with a total market value of
Companies Like Janux Therapeutics (NASDAQ:JANX) Can Afford To Invest In Growth
Janux Therapeutics Insider Sold Shares Worth $1,157,641, According to a Recent SEC Filing
Form 144 | Janux Therapeutics(JANX.US) Officer Proposes to Sell 4.35 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Sep 27, $Janux Therapeutics(JANX.US)$ Officer Campbell David Alan intends to sell 90,000 shares of its common stock on Sep 27, with a total market value of approximately $4.35
Is Janux Therapeutics Inc. (JANX) the Best Performing Small-Cap Stock in 2024?